RSV Webinar series - Introduction
As the world is dealing with the insistent daily spread of the Coronavirus, the ReSViNET Foundation wants to ensure the continuation of RSV education. Therefore, the ReSViNET Foundation has started a bi-monthly RSV Webinar Series on the latest developments in the RSV field. Each webinar will be based on a Paper of the Month (see publications), which will be discussed by one of the authors and a moderator, who will both be experts in the field. Participants will be able to ask questions and share their ideas with the presenters.
|
By means of this webinar series we strive to continue RSV education in an uncertain and changing environment due to the global COVID-19 pandemic. |
On this online platform, we will keep you updated on the rapid progressions in the field of RSV research and preventive and therapeutic interventions. |
We offer opportunities to interact with original authors and experts in the RSV field. So, together we can have an active learning experience. |
|
|
Testimonials |
|
"The moderating was very good, all questions were asked and answered. Also the speaker was excellent." |
|
"I appreciate the organization and the organizers for their efforts and the opportunity given to me to learn new things. Thank you!" |
|
"I found the presentation very interesting, and helpful for my research. It was good posting questions in the chat and having them answered at the end." |
|
"This series is very helpful." |
"Great job and always interesting!" |
|
"Keep bringing these excellent speakers. And leaving more time for discussion was actually great." |
|
|
Next webinar |
6. Save the date!
June 30TH, 2021
|
|
Webinar replays |
5. DETECTION OF DEFECTIVE VIRAL GENOMES AS A POTENTIAL TOOL TO PREDICT RESPIRATORY SYNCYTICAL VIRUS CLINICAL OUTCOME
May 27th, 2021
|
This webinar will focus on the detection of defective viral genomes (DVGs). Understanding the kinetics of DVG accumulation and duration could predict clinical outcomes of RSV A infection in humans and thus, could be used as a prognostic tool to identify patients at risk of worse clinical disease. Through interactive discussion and interview with guest speaker, prof. Carolina B. Lopez and co-host, dr. Ursula Buchholz, participants can ask questions directly to the speaker and they can take back lessons learned from these findings to their own research.
Hosted by Prof. dr. Louis Bont and moderated and organized by: Sophie Mazur, Roxie van Lieshout and Leyla Kragten-Tabatabaie. |
|
4. RSV DYNAMICS DURING THE COVID-19 PANDEMIC
March 25th, 2021
|
This webinar is focused on the spatiotemporal variation in epidemic timing of respiratory infections in relation to the COVID-19 pandemic. Through interactive discussion and interview with guest speaker, Dan Weinberger PhD, and co-host, dr. Renato Stein, participants could ask questions directly to the speaker and they can take back lessons learned from these findings to their own research.
Hosted by Prof. dr. Louis Bont and moderated and organized by: Sophie Mazur and Leyla Kragten-Tabatabaie. |
|
3. NEUTROPHILIC INFLAMMATION IN THE RESPIRATORY MUCOSA PREDISPOSES TO RSV INFECTION
JanUARY 27th, 2021
|
Why does RSV exposure in one individual lead to disease, while another individual does not experience symptoms at all? This webinar with guest speaker, prof. dr. Peter Openshaw and co-host, prof. dr. Linde Meyaard, focused on the mucosal neutrophil activation as a new factor involved in RSV susceptibility and protection.
Hosted by Prof. dr. Louis Bont and moderated and organized by: Amber Dassen, Sophie Mazur and Leyla Kragten-Tabatabaie. |
2. Lessons learned from the novavax phase 3 maternal vaccination trial
NovEMBER 20th, 2020
|
This webinar is focused on the outcomes of the Novavax phase 3 maternal vaccination trial examining the differential effect of vaccine efficacy in HICs versus LMICs. Through interactive discussion and interview with guest speaker, prof. Shabir Madhi, and co-host, dr. Jessie Groothuis, participants were able to ask questions directly to the speaker and expand on the lessons learned from this trial in their own research.
Hosted by Prof. dr. Louis Bont and moderated and organized by: Amber Dassen, Sophie Mazur and Leyla Kragten-Tabatabaie. |
|
1. HOW TO DESIGN AND MAKE YOUR OWN VACCINE PROTEIN?
SepTEMBER 24th, 2020
|
This webinar is focused on the novel development of the computationally designed protein-based vaccine using TopoBuilder, a protein design algorithm. Through interactive discussion and interview with guest speaker, dr. Fabian Sesterhenn, participants were able to ask questions directly to the speaker and learned skills which they can take back to their own research.
Hosted by Prof. dr. Louis Bont and moderated and organised by: Amber Dassen, Sophie Mazur and Leyla Kragten-Tabatabaie. |
